373 related articles for article (PubMed ID: 1672311)
1. A case of clozapine-induced neuroleptic malignant syndrome.
Miller DD; Sharafuddin MJ; Kathol RG
J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
[TBL] [Abstract][Full Text] [Related]
2. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
[TBL] [Abstract][Full Text] [Related]
3. Successful use of clozapine in a patient with a history of neuroleptic malignant syndrome.
Stoudemire A; Clayton L
J Neuropsychiatry Clin Neurosci; 1989; 1(3):303-5. PubMed ID: 2577714
[TBL] [Abstract][Full Text] [Related]
4. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
Illing M; Ancill R
Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
[No Abstract] [Full Text] [Related]
5. Atypical neuroleptic malignant syndrome with long-term clozapine.
Corallo CE; Ernest D
Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced neuroleptic malignant syndrome.
DasGupta K; Young A
J Clin Psychiatry; 1991 Mar; 52(3):105-7. PubMed ID: 2005072
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome and clozapine.
Reddig S; Minnema AM; Tandon R
Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome associated with clozapine monotherapy.
Thornberg SA; Ereshefsky L
Pharmacotherapy; 1993; 13(5):510-4. PubMed ID: 8247922
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
[TBL] [Abstract][Full Text] [Related]
10. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
11. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
Weller M; Kornhuber J
Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
[TBL] [Abstract][Full Text] [Related]
12. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
Kucia K; Warchala A
Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
[TBL] [Abstract][Full Text] [Related]
13. The neuroleptic malignant syndrome--a review.
Gibb WR; Lees AJ
Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
[TBL] [Abstract][Full Text] [Related]
14. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
[TBL] [Abstract][Full Text] [Related]
15. [Malignant neuroleptic syndrome in patients with dementia].
Malling BJ
Ugeskr Laeger; 1999 Apr; 161(17):2541-2. PubMed ID: 10327877
[TBL] [Abstract][Full Text] [Related]
16. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome associated with clozapine use.
Anderson ES; Powers PS
J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
[TBL] [Abstract][Full Text] [Related]
18. ["Catatonic dilemma". Therapy with lorazepam and clozapine].
Lausberg H; Hellweg R
Nervenarzt; 1998 Sep; 69(9):818-22. PubMed ID: 9789276
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
Margetić B; Aukst-Margetić B
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
